Ana Sofia Ore Carranza, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rectal Neoplasms | 4 | 2023 | 1157 | 1.090 |
Why?
|
| Surgical Stapling | 2 | 2022 | 98 | 0.990 |
Why?
|
| Colitis, Ulcerative | 3 | 2023 | 1922 | 0.800 |
Why?
|
| Ileostomy | 1 | 2022 | 121 | 0.750 |
Why?
|
| Diverticulitis, Colonic | 1 | 2022 | 138 | 0.740 |
Why?
|
| Suture Techniques | 2 | 2022 | 771 | 0.730 |
Why?
|
| Pancreatectomy | 3 | 2021 | 810 | 0.720 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2022 | 2421 | 0.590 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2019 | 284 | 0.550 |
Why?
|
| Colectomy | 6 | 2023 | 688 | 0.550 |
Why?
|
| Genital Neoplasms, Female | 1 | 2019 | 532 | 0.470 |
Why?
|
| Neoadjuvant Therapy | 3 | 2023 | 2823 | 0.470 |
Why?
|
| Crohn Disease | 2 | 2022 | 2279 | 0.430 |
Why?
|
| Laparoscopy | 3 | 2023 | 2035 | 0.410 |
Why?
|
| Preoperative Care | 1 | 2021 | 2242 | 0.400 |
Why?
|
| General Surgery | 1 | 2022 | 1692 | 0.380 |
Why?
|
| Venous Thromboembolism | 1 | 2022 | 1866 | 0.330 |
Why?
|
| Anastomosis, Surgical | 2 | 2022 | 983 | 0.320 |
Why?
|
| Colorectal Neoplasms | 2 | 2024 | 6901 | 0.280 |
Why?
|
| Abortion, Induced | 1 | 2021 | 462 | 0.250 |
Why?
|
| Hypoalbuminemia | 1 | 2023 | 86 | 0.210 |
Why?
|
| Regression Analysis | 2 | 2024 | 6341 | 0.210 |
Why?
|
| Internship and Residency | 1 | 2022 | 5877 | 0.200 |
Why?
|
| Swine | 2 | 2022 | 5915 | 0.200 |
Why?
|
| Colon, Sigmoid | 1 | 2022 | 124 | 0.200 |
Why?
|
| Pancreatic Neoplasms | 1 | 2019 | 5363 | 0.190 |
Why?
|
| Jejunum | 1 | 2022 | 472 | 0.170 |
Why?
|
| Colorectal Surgery | 1 | 2021 | 122 | 0.160 |
Why?
|
| Abdominal Muscles | 1 | 2019 | 168 | 0.150 |
Why?
|
| Retrospective Studies | 11 | 2023 | 80575 | 0.150 |
Why?
|
| Bibliometrics | 1 | 2021 | 352 | 0.140 |
Why?
|
| Minority Groups | 1 | 2024 | 1203 | 0.130 |
Why?
|
| Education, Medical, Continuing | 1 | 2021 | 824 | 0.130 |
Why?
|
| Cicatrix | 1 | 2022 | 798 | 0.130 |
Why?
|
| Interdisciplinary Communication | 1 | 2021 | 931 | 0.120 |
Why?
|
| Humans | 23 | 2024 | 761326 | 0.120 |
Why?
|
| Postoperative Complications | 5 | 2023 | 15647 | 0.120 |
Why?
|
| Collagen | 1 | 2022 | 2638 | 0.120 |
Why?
|
| Neuroendocrine Tumors | 1 | 2020 | 642 | 0.120 |
Why?
|
| Triage | 1 | 2020 | 986 | 0.110 |
Why?
|
| Gastrectomy | 1 | 2018 | 671 | 0.110 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2020 | 953 | 0.100 |
Why?
|
| Neoplasm Staging | 3 | 2023 | 11098 | 0.100 |
Why?
|
| Nerve Block | 1 | 2019 | 705 | 0.100 |
Why?
|
| Adenoma | 1 | 2022 | 2159 | 0.100 |
Why?
|
| Lymph Node Excision | 1 | 2018 | 1273 | 0.100 |
Why?
|
| Colonic Neoplasms | 1 | 2023 | 2534 | 0.100 |
Why?
|
| Robotics | 1 | 2018 | 819 | 0.090 |
Why?
|
| Potassium Chloride | 1 | 2021 | 230 | 0.090 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 2373 | 0.090 |
Why?
|
| Dilatation | 1 | 2021 | 307 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2019 | 2221 | 0.080 |
Why?
|
| Fetal Death | 1 | 2021 | 435 | 0.080 |
Why?
|
| Pain, Postoperative | 1 | 2019 | 1737 | 0.080 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2021 | 731 | 0.080 |
Why?
|
| Injections | 1 | 2021 | 830 | 0.070 |
Why?
|
| Stomach Neoplasms | 1 | 2018 | 1432 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2022 | 4793 | 0.070 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 3889 | 0.060 |
Why?
|
| Risk Factors | 2 | 2022 | 74152 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2021 | 3429 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2022 | 2853 | 0.060 |
Why?
|
| Colonoscopy | 2 | 2022 | 1394 | 0.060 |
Why?
|
| Aged | 6 | 2023 | 169179 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15835 | 0.050 |
Why?
|
| Inflammation | 1 | 2022 | 10760 | 0.050 |
Why?
|
| Female | 8 | 2022 | 392485 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 3801 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3080 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3200 | 0.050 |
Why?
|
| Animals | 3 | 2022 | 168388 | 0.050 |
Why?
|
| Quality of Life | 1 | 2023 | 13355 | 0.050 |
Why?
|
| Ileum | 1 | 2022 | 557 | 0.040 |
Why?
|
| Middle Aged | 5 | 2021 | 220774 | 0.040 |
Why?
|
| Learning Curve | 1 | 2021 | 230 | 0.040 |
Why?
|
| Male | 7 | 2023 | 360621 | 0.040 |
Why?
|
| Communication Barriers | 1 | 2022 | 413 | 0.040 |
Why?
|
| United States | 2 | 2024 | 72317 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 26108 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2021 | 41440 | 0.040 |
Why?
|
| Blood Loss, Surgical | 1 | 2021 | 636 | 0.040 |
Why?
|
| Intraoperative Complications | 1 | 2023 | 1165 | 0.030 |
Why?
|
| Databases, Factual | 2 | 2023 | 7954 | 0.030 |
Why?
|
| Rectum | 1 | 2020 | 892 | 0.030 |
Why?
|
| Bupivacaine | 1 | 2019 | 412 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 21009 | 0.030 |
Why?
|
| Colon | 1 | 2022 | 1792 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2019 | 2217 | 0.030 |
Why?
|
| Propensity Score | 1 | 2021 | 1908 | 0.030 |
Why?
|
| Language | 1 | 2022 | 1539 | 0.030 |
Why?
|
| Adult | 4 | 2021 | 221122 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 2273 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2019 | 3419 | 0.030 |
Why?
|
| Reference Values | 1 | 2019 | 4921 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 4850 | 0.020 |
Why?
|
| Linear Models | 1 | 2021 | 5871 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2023 | 64645 | 0.020 |
Why?
|
| Recurrence | 1 | 2022 | 8470 | 0.020 |
Why?
|
| Pregnancy | 1 | 2021 | 29858 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2019 | 3552 | 0.020 |
Why?
|
| Massachusetts | 1 | 2021 | 8837 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2022 | 3200 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2023 | 3800 | 0.020 |
Why?
|
| Patient Selection | 1 | 2020 | 4244 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39108 | 0.020 |
Why?
|
| Length of Stay | 1 | 2021 | 6422 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 10764 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 9275 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2019 | 22124 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8635 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29588 | 0.010 |
Why?
|
| Mice | 1 | 2022 | 81474 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 58946 | 0.010 |
Why?
|